We're Not Very Worried About Mineralys Therapeutics' (NASDAQ:MLYS) Cash Burn Rate

By Yahoo! Finance | Oct 20, 2024 at 09:30 AM EST

Even with losses, shareholders can profit by investing in a good business at the right price. Mineralys Therapeutics (NASDAQ:MLYS) has a solid cash runway but increasing cash burn. Shareholders should monitor growth and potential need for more cash.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.